| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom; and Lung Biology Research Program, Hospital for Sick Children Research Institute, Toronto, Canada
Peptidoglycan (PGN) is the major cell wall component (90%, w/w) of Gram-positive bacteria and consists of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) disaccharide repeating arrays that are cross-linked by short peptides. We hypothesized that PGN is a ligand for pathogen-associated pattern-recognition proteins. Mannose-binding lectin (MBL) and serum amyloid component P are two carbohydrate-binding innate immune proteins present in the blood. In this study we show that human MBL, but not serum amyloid component P, binds significantly to PGN via its C-type lectin domains, and that the interaction can be more effectively competed by GlcNAc than by MurNAc. Surface plasmon resonance analyses show that native MBL binds immobilized PGN with high avidity. Competition experiments also show that both native MBL and MBL(n/CRD), a 48-kDa recombinant trimeric fragment of MBL containing neck and carbohydrate recognition domains, have higher affinity for GlcNAc than for MurNAc. Protein arrays and ELISA show that PGN increases the secretion of TNF-
, IL-8, IL-10, MCP-2, and RANTES from PMA-stimulated human monocytic U937 cells. Interestingly, the presence of MBL together with PGN increases the production of IL-8 and RANTES, but reduces that of TNF-. Our results indicate that Gram-positive bacterial is a biologically relevant ligand for MBL, and that the collectin preferentially binds to the GlcNAc moiety of the PGN via its C-type lectin domains. MBL inhibits PGN-induced production of proinflammatory cytokines while enhancing the production of chemokines by macrophages, which suggests that MBL may down-regulate macrophage-mediated inflammation while enhancing phagocyte recruitment.
This article has been cited by other articles:
|
|
 |
|
  C. Rennemeier, S. Hammerschmidt, S. Niemann, S. Inamura, U. Zahringer, and B. E. Kehrel Thrombospondin-1 promotes cellular adherence of Gram-positive pathogens via recognition of peptidoglycan FASEB J, October 1, 2007; 21(12): 3118 - 3132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Mullaly and P. Kubes The Role of TLR2 In Vivo following Challenge with Staphylococcus aureus and Prototypic Ligands J. Immunol., December 1, 2006; 177(11): 8154 - 8163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Keller, S. I. van Leuven, M. C. Meuwese, N. J. Wareham, R. Luben, E. S. Stroes, C. E. Hack, M. Levi, K.-T. Khaw, and S. M. Boekholdt Serum Levels of Mannose-Binding Lectin and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2345 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. L. Cash, C. V. Whitham, C. L. Behrendt, and L. V. Hooper Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science, August 25, 2006; 313(5790): 1126 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Patrone, S. E. Bish, and D. C. Stein TNF-{alpha}-Independent IL-8 Expression: Alterations in Bacterial Challenge Dose Cause Differential Human Monocytic Cytokine Response J. Immunol., July 15, 2006; 177(2): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S I van Leuven, J J. Kastelein, D P D'Cruz, G R Hughes, and E S Stroes Atherogenesis in rheumatology Lupus, March 1, 2006; 15(3): 117 - 121. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
